Syndrome of inappropriate antidiuretic hormone differential diagnosis: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
|||
Line 7: | Line 7: | ||
==Differentiating Syndrome of inappropriate antidiuretic hormone from other Diseases== | ==Differentiating Syndrome of inappropriate antidiuretic hormone from other Diseases== | ||
[[SIADH]] must be differentiated from | [[SIADH]] must be differentiated from cerebral salt wasting, [[ adrenal insufficiency]], [[hypopituitarism]], [[hypothyroidism]], and [[psychogenic polydipsia]]<ref name="pmid27936532">{{cite journal |vauthors=Heidelbaugh JJ |title=Endocrinology Update: Hypopituitarism |journal=FP Essent |volume=451 |issue= |pages=25–30 |year=2016 |pmid=27936532 |doi= |url=}}</ref><ref name="pmid15241506">{{cite journal |vauthors=Hammer F, Arlt W |title=[Hypopituitarism] |language=German |journal=Internist (Berl) |volume=45 |issue=7 |pages=795–811; quiz 812–3 |year=2004 |pmid=15241506 |doi=10.1007/s00108-004-1216-5 |url=}}</ref><ref name="pmid25712898">{{cite journal |vauthors=de Fost M, Oussaada SM, Endert E, Linthorst GE, Serlie MJ, Soeters MR, DeVries JH, Bisschop PH, Fliers E |title=The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsia |journal=Endocr Connect |volume=4 |issue=2 |pages=86–91 |year=2015 |pmid=25712898 |pmc=4401105 |doi=10.1530/EC-14-0113 |url=}}</ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 19: | Line 19: | ||
|[[SIADH]] is a syndrome characterized by excessive release of [[Vasopressin|antidiuretic hormone]] (ADH or vasopressin) from the [[posterior pituitary]] gland or another source. The result is [[hyponatremia]], and sometimes [[fluid]] overload. | |[[SIADH]] is a syndrome characterized by excessive release of [[Vasopressin|antidiuretic hormone]] (ADH or vasopressin) from the [[posterior pituitary]] gland or another source. The result is [[hyponatremia]], and sometimes [[fluid]] overload. | ||
| | | | ||
*[[Nausea/vomiting]] | *[[Nausea]] / [[vomiting]] | ||
*[[Cramps]] | *[[Cramps]] | ||
*[[Depressed mood]] | *[[Depressed mood]] | ||
*[[Irritability]] | *[[Irritability]] | ||
*[[Confusion]] | *[[Confusion]] | ||
*[[ Hallucinations]] | *[[ Hallucinations]] | ||
*[[Seizures]] ,[[stupor]] or [[coma ]] | *[[Seizures]] ,[[stupor]] or [[coma ]] | ||
| | | | ||
Line 50: | Line 50: | ||
|The patient is | |The patient is | ||
*[[Hypovolemic]] | *[[Hypovolemic]] | ||
*[[Hyponatremic]] | *[[Hyponatremia|Hyponatremic]] | ||
|Treatment is with adequate | |Treatment is with adequate | ||
*[[Hydration]] and | *[[Hydration]] and | ||
*[[Sodium]] replacement | *[[Sodium]] replacement | ||
|- | |- | ||
|[[Adrenal insufficiency]] | |[[Adrenal insufficiency]] | ||
Line 93: | Line 93: | ||
*[[Orthostatic hypotension]]. | *[[Orthostatic hypotension]]. | ||
Acute [[addisonian]] crisis is characterized by : | Acute [[addisonian]] crisis is characterized by: | ||
*[[Fever]] | *[[Fever]] | ||
*[[ Hypotension]] | *[[ Hypotension]] | ||
|The diagnosis of [[Addisons]] disease is made through rapid [[ACTH]] administration and measurement of [[cortisol]]. | |The diagnosis of [[Addisons]] disease is made through rapid [[ACTH]] administration and measurement of [[cortisol]]. | ||
*Lab findings include: | *Lab findings include: | ||
Line 145: | Line 145: | ||
* Decreased [[facial]] or[[ body hair]] in men | * Decreased [[facial]] or[[ body hair]] in men | ||
* [[Short stature]] in children | * [[Short stature]] in children | ||
|The diagnosis is based on detailed investigation of symptoms of target endocrine gland function relative to the corresponding pituitary[[ hormone]] deficiency | |The diagnosis is based on detailed investigation of symptoms of target endocrine gland function relative to the corresponding pituitary[[ hormone]] deficiency | ||
The clinical manifestations of[[ hypopituitarism]] result from the degree of the specific hormone [[deficiency]] | |||
A thorough and longitudinal [[history]] and[[ physical examination]], including [[visual field]] testing, are important. | A thorough and longitudinal [[history]] and[[ physical examination]], including [[visual field]] testing, are important. | ||
Hypopituitarism may involve from one to all endocrine axes regulated by the pituitary | Hypopituitarism may involve from one to all endocrine axes regulated by the pituitary | ||
Line 156: | Line 157: | ||
*[[ Growth hormone]] | *[[ Growth hormone]] | ||
*[[Surgery]] and/or | *[[Surgery]] and/or | ||
*[[ Radiotherapy]] to restore normal [[endocrine]] function and quality of life | *[[ Radiotherapy]] to restore normal [[endocrine]] function and quality of life | ||
*Patients with hypopituitarism require lifelong monitoring of serum hormone levels and symptoms of hormone deficiency or excess | *Patients with hypopituitarism require lifelong monitoring of serum hormone levels and symptoms of hormone deficiency or excess | ||
*Long-term care and monitoring of patients with hypopituitarism requires a experienced [[endocrinologist]] | *Long-term care and monitoring of patients with hypopituitarism requires a experienced [[endocrinologist]] | ||
|- | |- | ||
|[[Hypothyroidism]] | |[[Hypothyroidism]] | ||
Line 188: | Line 189: | ||
*Signs and symptoms are neither [[sensitive]] nor [[specific]] for the diagnosis. | *Signs and symptoms are neither [[sensitive]] nor [[specific]] for the diagnosis. | ||
*TSH is the most sensitive tool for screening,diagnosis and treatment follow up, when[[ pituitary]] is normal. | *TSH is the most sensitive tool for screening,diagnosis and treatment follow up, when[[ pituitary]] is normal. | ||
*The drug of choice for treatment is [[Levothyroxine]] | *The drug of choice for treatment is [[Levothyroxine]] | ||
|- | |- | ||
|[[Psychogenic polydipsia]] | |[[Psychogenic polydipsia]] | ||
Line 203: | Line 204: | ||
*[[Psychosis]] | *[[Psychosis]] | ||
*[[Seizures]] and | *[[Seizures]] and | ||
*Sometimes, even | *Sometimes, even death | ||
|Evaluation of[[ psychiatric]] patients with polydipsia warrants a comprehensive evaluation for other medical causes of polydipsia, polyuria,[[ hyponatremia]], and the syndrome of inappropriate secretion of antidiuretic hormone. | |Evaluation of[[ psychiatric]] patients with polydipsia warrants a comprehensive evaluation for other medical causes of polydipsia, polyuria,[[ hyponatremia]], and the syndrome of inappropriate secretion of antidiuretic hormone. | ||
*The management strategy in[[ psychiatric]] patients should include: | *The management strategy in[[ psychiatric]] patients should include: | ||
*[[Fluid]] restriction and[[ behavioral]] and [[pharmacologic]] modalities. | *[[Fluid]] restriction and[[ behavioral]] and [[pharmacologic]] modalities. | ||
*The [[water deprivation test]] is the [[gold standard]] test | *The [[water deprivation test]] is the [[gold standard]] test | ||
|} | |} | ||
Revision as of 20:47, 24 August 2017
Syndrome of inappropriate antidiuretic hormone Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Syndrome of inappropriate antidiuretic hormone differential diagnosis On the Web |
American Roentgen Ray Society Images of Syndrome of inappropriate antidiuretic hormone differential diagnosis |
FDA on Syndrome of inappropriate antidiuretic hormone differential diagnosis |
CDC on Syndrome of inappropriate antidiuretic hormone differential diagnosis |
Syndrome of inappropriate antidiuretic hormone differential diagnosis in the news |
Blogs on Syndrome of inappropriate antidiuretic hormone differential diagnosis |
Directions to Hospitals Treating Syndrome of inappropriate antidiuretic hormone |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
SIADH consists ofhyponatremia, inappropriately elevatedurine osmolality, excessive urine sodium and decreased serum osmolality in a euvolemic patient without edema. These findings should occur in the absence of diuretic treatment with normal cardiac, renal, adrenal, hepatic and thyroid function.Hyponatremia occurs in about 30% of hospitalized patients and SIADH is the most frequent cause of hyponatremia. Differentiating hyponatremia due to SIADH from other causes of hyponatremia becomes essential to evaluate the treatment plan. Syndrome of inappropriate antidiuretic hormone must be differentiated from cerebral salt wasting , adrenal insufficiency, hypopituitarism, hypothyroidism,psychogenic polydipsia
Differentiating Syndrome of inappropriate antidiuretic hormone from other Diseases
SIADH must be differentiated from cerebral salt wasting, adrenal insufficiency, hypopituitarism, hypothyroidism, and psychogenic polydipsia[1][2][3]
Disease | Causes | Symptoms | Diagnosis and treatment |
---|---|---|---|
SIADH | SIADH is a syndrome characterized by excessive release of antidiuretic hormone (ADH or vasopressin) from the posterior pituitary gland or another source. The result is hyponatremia, and sometimes fluid overload. |
| |
Cerebral salt wasting syndrome | Cerebral salt wasting syndrome is defined as therenal loss of sodium during intracranial disease leading to hyponatremia and a decrease in extracellular fluid volume. | The patient is | Treatment is with adequate |
Adrenal insufficiency | Adrenal insufficiency ranges from mild nonspecific symptoms to life-threatening shock like condition.
An important distinction in these patients is the presence ofmineralocorticoid deficiency. Those with secondary or tertiary adrenal insufficiency will typically have preservedmineralocorticoid function due to the separate feedback systems. Adrenal insufficiency can be Tertiary Common causes of primary adrenal insufficiency:
|
Chronic disease is characterized by Acute addisonian crisis is characterized by: |
The diagnosis of Addisons disease is made through rapid ACTH administration and measurement of cortisol.
The definitive diagnosis is the cosyntropin or ACTH stimulation test. Acortisol level is obtained before and after administering ACTH. A normal person should show a brisk rise in cortisol level after ACTH administration.
Adrenal crisis:
|
Hypopituitarism | Hypopituitarism is defined as the partial or complete loss of anterior pituitary function that can result from acquired or congenital causes.
Etiology is as follows: |
Signs and symptoms ofhypopituitarism vary, depending on the deficient hormone and severity of the disorder,some of the symptoms may be as follows:
|
The diagnosis is based on detailed investigation of symptoms of target endocrine gland function relative to the corresponding pituitaryhormone deficiency
The clinical manifestations ofhypopituitarism result from the degree of the specific hormone deficiency A thorough and longitudinal history andphysical examination, including visual field testing, are important. Hypopituitarism may involve from one to all endocrine axes regulated by the pituitary In order of frequency: growth hormone deficiency>secondary hypogonadism>secondary hypothyroidism>secondary adrenal failure). The treatment of permanent hypopituitarism consists of replacement of the peripheral hormones
|
Hypothyroidism | Hypofunctioning of the thyroid gland due to multifactorial etiology ranging from congenital to autoimmune causes described below:
|
|
Diagnosis of hypothyroidism is based on blood tests:
|
Psychogenic polydipsia | Also called asprimary polydipsia is characterized bypolyuria and polydipsia. Causes are:
|
Evaluation ofpsychiatric patients with polydipsia warrants a comprehensive evaluation for other medical causes of polydipsia, polyuria,hyponatremia, and the syndrome of inappropriate secretion of antidiuretic hormone.
|
References
- ↑ Heidelbaugh JJ (2016). "Endocrinology Update: Hypopituitarism". FP Essent. 451: 25–30. PMID 27936532.
- ↑ Hammer F, Arlt W (2004). "[Hypopituitarism]". Internist (Berl) (in German). 45 (7): 795–811, quiz 812–3. doi:10.1007/s00108-004-1216-5. PMID 15241506.
- ↑ de Fost M, Oussaada SM, Endert E, Linthorst GE, Serlie MJ, Soeters MR, DeVries JH, Bisschop PH, Fliers E (2015). "The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsia". Endocr Connect. 4 (2): 86–91. doi:10.1530/EC-14-0113. PMC 4401105. PMID 25712898.